Free Trial
OTCMKTS:PPCB

Propanc Biopharma (PPCB) Stock Price, News & Analysis

Propanc Biopharma logo
$6.00 0.00 (0.00%)
As of 07/11/2025

About Propanc Biopharma Stock (OTCMKTS:PPCB)

Key Stats

Today's Range
$6.00
$6.00
50-Day Range
$1.99
$8.00
52-Week Range
$1.25
$145.46
Volume
45 shs
Average Volume
2,193 shs
Market Capitalization
$114 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PPCB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Propanc Biopharma and its competitors with MarketBeat's FREE daily newsletter.

PPCB Stock News Headlines

Propanc Biopharma Inc (PPCB)
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
VTXB Vortex Brands Co.
Propanc Biopharma, Inc. (PPCB)
See More Headlines

PPCB Stock Analysis - Frequently Asked Questions

Propanc Biopharma's stock was trading at $0.0002 at the start of the year. Since then, PPCB shares have increased by 2,999,900.0% and is now trading at $6.00.

Propanc Biopharma Inc (OTCMKTS:PPCB) released its earnings results on Thursday, May, 15th. The company reported ($12.50) earnings per share for the quarter.

Propanc Biopharma shares reverse split on the morning of Tuesday, May 23rd 2023.The 1-1000 reverse split was announced on Tuesday, May 23rd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, May 23rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 0 shares after the split.

Shares of PPCB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Propanc Biopharma investors own include T2 Biosystems (TTOO), AppYea (APYP), Avis Budget Group (CAR), PayPal (PYPL), Synthetic Biologics (SYN), Corbus Pharmaceuticals (CRBP) and Delcath Systems (DCTH).

Company Calendar

Last Earnings
5/15/2025
Today
7/13/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:PPCB
CIK
1517681
Employees
1
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$1.82 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-3,652.66%
Return on Assets
-971.09%

Debt

Debt-to-Equity Ratio
0.01
Current Ratio
2.24
Quick Ratio
2.24

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($493.34) per share
Price / Book
-0.01

Miscellaneous

Outstanding Shares
19,000
Free Float
19,000
Market Cap
$114 thousand
Optionable
Not Optionable
Beta
2.52
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (OTCMKTS:PPCB) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners